Literature DB >> 13131825

Phenylbutazone therapy; relation between the toxic and therapeutic effects and the blood level.

E BRUCK, M E FEARNLEY, I MEANOCK, H PATLEY.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; RHEUMATISM/therapy

Mesh：

Substances：

Year:  1954        PMID： 13131825     DOI： 10.1016/s0140-6736(54)90874-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  ANALGESIC DRUGS FOR RHEUMATISM.

Authors:  M E SMITH; J GOUGH; O P GALPIN
Journal:  Br Med J       Date:  1963-11-23

2.  Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy.

Authors:  J M MACCARTHY; R T JACKSON
Journal:  Br Med J       Date:  1955-07-23

3.  An appraisal of phenylbutazone suppositories.

Authors:  C F HAWKINS; H T FAWNS
Journal:  Br Med J       Date:  1959-10-17

4.  [Action mechanism of butazolidine; effects on the heparin tolerance test and on the erythrocyte sedimentation rate in vitro].

Authors:  W BEIGLBOCK; H KAISER
Journal:  Klin Wochenschr       Date:  1956-05-15

5.  Acute renal failure after phenylbutazone.

Authors:  R BOLTON; H BARRIE
Journal:  Br Med J       Date:  1955-02-05

6.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

7.  Parazolidin: a new compound analgesic preparation.

Authors:  M Lloyd-Jones; A U Campbell
Journal:  J Coll Gen Pract       Date:  1966-05

Review 8.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

9.  Genetic control of phenylbutazone metabolism in man.

Authors:  J A Whittaker; D A Evans
Journal:  Br Med J       Date:  1970-11-07

10.  Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis.

Authors:  M Orme; P J Holt; G R Hughes; C J Bulpitt; G H Draffan; S S Thorgeirsson; F Williams; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.